Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 4 studies | 26% ± 12% |
Insufficient scRNA-seq data for expression of APLN at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1528.38 | 2636 / 2642 | 100% | 93.29 | 704 / 705 |
adrenal gland | 92% | 801.40 | 237 / 258 | 81% | 35.36 | 186 / 230 |
kidney | 96% | 933.24 | 85 / 89 | 72% | 69.63 | 647 / 901 |
lung | 84% | 1083.36 | 486 / 578 | 56% | 10.20 | 642 / 1155 |
breast | 65% | 486.52 | 300 / 459 | 58% | 9.40 | 649 / 1118 |
ovary | 66% | 310.39 | 118 / 180 | 54% | 9.13 | 231 / 430 |
heart | 94% | 912.20 | 809 / 861 | 0% | 0 | 0 / 0 |
prostate | 30% | 119.75 | 74 / 245 | 62% | 11.01 | 309 / 502 |
intestine | 23% | 96.61 | 219 / 966 | 59% | 9.79 | 313 / 527 |
stomach | 23% | 95.57 | 84 / 359 | 58% | 9.81 | 166 / 286 |
esophagus | 28% | 114.34 | 409 / 1445 | 49% | 8.62 | 90 / 183 |
bladder | 24% | 488.95 | 5 / 21 | 47% | 8.43 | 235 / 504 |
skin | 38% | 156.44 | 679 / 1809 | 31% | 4.74 | 148 / 472 |
blood vessel | 66% | 1134.81 | 882 / 1335 | 0% | 0 | 0 / 0 |
uterus | 14% | 65.18 | 24 / 170 | 45% | 11.66 | 206 / 459 |
liver | 18% | 98.36 | 41 / 226 | 39% | 6.33 | 160 / 406 |
adipose | 57% | 561.70 | 687 / 1204 | 0% | 0 | 0 / 0 |
thymus | 18% | 112.61 | 119 / 653 | 30% | 4.71 | 181 / 605 |
tonsil | 0% | 0 | 0 / 0 | 47% | 6.95 | 21 / 45 |
muscle | 34% | 262.79 | 276 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 28% | 3.61 | 22 / 80 |
pancreas | 2% | 4.34 | 5 / 328 | 22% | 3.47 | 40 / 178 |
lymph node | 0% | 0 | 0 / 0 | 14% | 1.66 | 4 / 29 |
spleen | 10% | 89.64 | 25 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 4% | 8.96 | 34 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042756 | Biological process | drinking behavior |
GO_0001525 | Biological process | angiogenesis |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_1904706 | Biological process | negative regulation of vascular associated smooth muscle cell proliferation |
GO_0007165 | Biological process | signal transduction |
GO_1905564 | Biological process | positive regulation of vascular endothelial cell proliferation |
GO_0060976 | Biological process | coronary vasculature development |
GO_0007369 | Biological process | gastrulation |
GO_1904022 | Biological process | positive regulation of G protein-coupled receptor internalization |
GO_0006955 | Biological process | immune response |
GO_0045776 | Biological process | negative regulation of blood pressure |
GO_1902895 | Biological process | positive regulation of miRNA transcription |
GO_0045823 | Biological process | positive regulation of heart contraction |
GO_0007595 | Biological process | lactation |
GO_0040037 | Biological process | negative regulation of fibroblast growth factor receptor signaling pathway |
GO_0060183 | Biological process | apelin receptor signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005179 | Molecular function | hormone activity |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0031704 | Molecular function | apelin receptor binding |
Gene name | APLN |
Protein name | Apelin (APJ endogenous ligand) [Cleaved into: Apelin-36; Apelin-31; Apelin-28; Apelin-13] |
Synonyms | APEL |
Description | FUNCTION: Endogenous ligand for the apelin receptor (APLNR) . Drives internalization of the apelin receptor (By similarity). Apelin-36 dissociates more hardly than (pyroglu)apelin-13 from APLNR (By similarity). Hormone involved in the regulation of cardiac precursor cell movements during gastrulation and heart morphogenesis (By similarity). Has an inhibitory effect on cytokine production in response to T-cell receptor/CD3 cross-linking; the oral intake of apelin in the colostrum and the milk might therefore modulate immune responses in neonates (By similarity). Plays a role in early coronary blood vessels formation (By similarity). Mediates myocardial contractility in an ERK1/2-dependent manner (By similarity). May also have a role in the central control of body fluid homeostasis by influencing vasopressin release and drinking behavior (By similarity). .; FUNCTION: (Microbial infection) Endogenous ligand for the apelin receptor (APLNR), an alternative coreceptor with CD4 for HIV-1 infection . Inhibits HIV-1 entry in cells coexpressing CD4 and APLNR . Apelin-36 has a greater inhibitory activity on HIV infection than other synthetic apelin derivatives . . |
Accessions | ENST00000429967.3 Q9ULZ1 |